Sorrento Therapeutics Inc (SRNE) stock has fallen -21.46% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives SRNE stock a score of 34 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 4. SRNE's rank also includes a long-term technical score of 22. The fundamental score for SRNE is 76. In addition to the average rating from Wall Street analysts, SRNE stock has a mean target price of $26.67. This means analysts expect the stock to gain 341.49% over the next 12 months.
SRNE has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on SRNE!
Sorrento Therapeutics Inc (SRNE) stock has risen 15.05% while the S&P 500 is up 2.09% as of 1:51 PM on Tuesday, Dec 7. SRNE is up $0.79 from the previous closing price of $5.25 on volume of 5,755,766 shares. Over the past year the S&P 500 is up 26.97% while SRNE has fallen -21.46%. SRNE lost -$1.22 per share in the over the last 12 months.
Click Here to get the full Stock Report for Sorrento Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
